Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.
Vixiar Medical develops non-invasive, cost-effective devices, and systems for monitoring cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor, is a handheld point of care device and digital platform for monitoring worsening heart failure.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 20, 2019 | Series A | $1.50M | 2 | — | — | Detail |
Feb 20, 2018 | Series Unknown | $1.58M | 1 | — | — | Detail |
Jul 20, 2017 | Seed | $1.50M | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
— | Series A |
|
— | Series A |
![]() |
— | Series Unknown |